Cost and utilization of COPD and asthma among insured adults in the US

Current Medical Research and Opinion

Volumn 25, Issue 6, 2009, Pages 1385-1392

  Blanchette, Christopher M ^a,b   Broder, Michael ^c   Ory, Caron ^c   Chang, Eunice ^c   Akazawa, Manabu ^b   Dalal, Anand A ^d  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Chronic obstructive; Economics; Insurance claim review; Pulmonary disease

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COST OF ILLNESS; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 67649443936     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902875927     Document Type: Article

References (18)

1. Trends in chronic obstructive bronchitis and emphysema: morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services, 2006
2. Healthy People 2010 (conference edn., vol II). In: US Department of Health and Human Services W, DC, ed. 2000
3. Kardos P, Wencker M, Glaab T, et al. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:144-149 (Pubitemid 46115085)
4. Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005;143:317-326 (Pubitemid 41266605)
5. Stempel DASR, Kim J, Chernicoff HO, et al. Asthma related ED/hospitalization risk and asthma costs of fluticasone propionate/salmeterol in a single inhaler compared to fluticasone propionate and salmeterol in separate inhalers. J Allergy Clin Immunol 2004;113:S272
6. Trends in asthma: morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services, 2006
7. Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65 (Pubitemid 38943118)
8. Beeh KM, Kornmann O, Beier J, et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004;98:591-597 (Pubitemid 38949921)
9. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Int Med 2000;160:1683-1689
10. OCR privacy brief: summary of the HIPAA privacy rule. In: OFCR-HIPPA, ed.: Department of Health and Human Services, Office for Civil Rights, 2007
11. International Classification of Diseases, 9th Revision, Clinical Modification, 4th Edn. In: USDHHS, ed.: US Government Printing Office, Washington, DC. 1991
12. National Drug Code Directory. 2007. Available at: http://www.fda.gov/ cder/ndc/index.htm (Last accessed April 14, 2009)
13. Fan VS, Bryson CL, Curtis JR, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med 2003;168:1488-1494 (Pubitemid 38037334)
14. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383 (Pubitemid 17055592)
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619
16. SAS. SAS/STAT User's Guide, Version 9. 9th Edn. Cary, NC: SAS Institute, Inc., 2003
17. Bleecker ER. Similiarities and differences in asthma and COPD: the Dutch Hypothesis. Chest 2004;126(Suppl.):93S-95S (Pubitemid 39093397)
18. Nathell L, Larsson K, Jensen I. Determinants of undiagnosed asthma. Allergy. 2002;57:687-693 (Pubitemid 34836835)